Human FLT3/Flk-2 Protein, Accession: P36888

/在： /经由过程：
  • 产物概述
  • 产物规格
  • 运输及存储
  • 品牌申明

    • 产物概述

    产物描写

    Recombinant Human FLT3/Flk-2 Protein is expressed from HEK293 with hFc tag at the C-terminal.It contains Asn27-Asn541.

    Biotinylated

    产物规格

    靶点

    FLT3/Flk-2

    份子又名

    CD135; FLK2; STK-1; FLT-3

    Accession

    种属

    Human

    卵白序列

    Asn27-Asn541

    份子量

    The protein has a predicted MW of 84.9 kDa. Due to glycosylation, the protein migrates to 100-120 kDa based on Tris-Bis PAGE result.

    活性

    Immobilized Human FLT3 Ligand, His Tag at 1ug/ml (100ul/Well) on the plate. Dose response curve for Human FLT3, hFc Tag with the EC50 of 19.6ng/ml determined by ELISA. See testing image for detail.

    产物标签

    C-hFc

    抒发体系

    HEK293

    纯度

    > 95% as determined by Tris-Bis PAGE;> 95% as determined by HPLC

    内毒素

    Less than 1EU per ug by the LAL method.

    运输及存储

    产物表面

    Lyophilized

    运输前提

    Shipped at ambient temperature.

    制剂

    Lyophilized from 0.22um filtered solution in PBS (pH 7.4). Normally 5% trehalose is added as protectant before lyophilization.

    复溶

    Centrifuge tubes before opening. Reconstituting to a concentration more than 100 ug/ml is recommended. Dissolve the lyophilized protein in distilled water.

    存储和不变性

    Reconstituted protein stable at -80°C for 12 months, 4°C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 该副产物的企业品牌ChemWhat是Watson的注册公司钢种，由Watson受权福建海角社区 在全球国内地区借助，点此拜候。